SCHEMBL7445186

SCHEMBL7445186

CSc1cc(NC(=O)OC(C)(C)C)ccc1-c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 3/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA9 Q16790 1/20 0.42
ACSS2 Q9NR19 1/20 0.41
BRD4 O60885 2/20 0.41
CREBBP Q92793 2/20 0.41
BRD9 Q9H8M2 1/20 0.40
HDAC1 Q13547 4/20 0.40
HDAC4 P56524 2/20 0.40
PSMB8 P28062 1/20 0.39
NAMPT P43490 1/20 0.39
NR1I3 Q14994 2/20 0.39
BCL2 P10415 1/20 0.39
BECN1 Q14457 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
MAP4K4 O95819 1/20 0.39
HDAC3 O15379 3/20 0.39
HDAC2 Q92769 3/20 0.39
HDAC10 Q969S8 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6165687 0.84 BRD4 (0.48) CYP17A1BRD4CREBBPPSMB8NAMPT
SCHEMBL3783709 0.82 MAP4K4 (0.46) CYP17A1CA12CA1CA9ACSS2
SCHEMBL31263554 0.80 CA12 (0.52) CYP17A1CA12CA1CA9HDAC1
SCHEMBL28698567 0.80 ACHE (0.47) CYP17A1CA12CA1CA9HDAC1
SCHEMBL3784607 0.79 MAP4K4 (0.46) CYP17A1CA12CA1CA9ACSS2
SCHEMBL6154023 0.79 CA12 (0.45) CYP17A1CA12CA1CA9HDAC1
SCHEMBL29225770 0.78 S1PR1 (0.45) CYP17A1CA12CA1CA9ACSS2
SCHEMBL18570243 0.77 CYP17A1 (0.61) CYP17A1PSMB8NAMPTBCL2BECN1
Phosphine SCHEMBL27819890 0.77 ACSS2 (0.44) CYP17A1CA12CA1CA9ACSS2
SCHEMBL13754832 0.76 CYP17A1 (0.64) CYP17A1BRD4CREBBPHDAC1HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0946528-A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS Du Pont Pharmaceuticals Company (US) 1999-10-06 EP disclosed
WO-1998028282-A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1998-07-02 WO disclosed